ArticleThe oncologist2018

A First-in-Human Phase I Study of OPB-111077, a Small-Molecule STAT3 and Oxidative Phosphorylation Inhibitor, in Patients with Advanced Cancers.

Anthony Tolcher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.